IJsselmuiden Alexander J J, Cotton James M, Slagboom Ton, van der Wieken Ron, Kiemeneij Ferdinand, Serruys Patrick W, Laarman GertJan
Amsterdam Department of Interventional Cardiology-OLVG, Amsterdam, The Netherlands.
Int J Cardiovasc Intervent. 2003;5(2):72-6. doi: 10.1080/14628840310003253.
To evaluate the safety and efficacy of the direct implantation of a new stent via the radial artery through a 5 F. guiding catheter. Background advances in the design of stents and stent delivery systems have facilitated the performance of direct stenting and the use of thinner guiding catheters.
This registry enrolled prospectively 125 patients (147 lesions, 20.4% AHA/ACC class B2/C) who underwent elective percutaneous coronary revascularization procedures for stable or unstable angina between November 2000 and March 2001.
Cannulation of the radial artery was attempted in 92.7% and was successful in 91.0% of cases. Direct stenting was successful in 88.7% of lesions and procedural success was 99.3%. In-hospital major adverse cardiac events occurred in 1.6% of cases (one death, one semi-urgent coronary artery bypass operation). The final rate of successful stent implantation through 5 F. guiding catheters was 96.7%. There were no access-site-related complications. Failure to cross the lesion occurred in 10% of attempts. At a mean follow-up of 7 +/- 2.8 months after discharge from hospital, 79% of patients had remained free of angina, and 89% had remained free of ischemic events.
Direct stenting with a new stent design was safe, effective, and could be accomplished through 5 F. guiding catheters with favorable long-term clinical outcomes.
评估经5F引导导管经桡动脉直接植入新型支架的安全性和有效性。背景:支架及支架输送系统设计的进展促进了直接支架置入术的开展及更细引导导管的使用。
该注册研究前瞻性纳入了125例患者(147处病变,20.4%为美国心脏协会/美国心脏病学会B2/C级),这些患者在2000年11月至2001年3月期间因稳定或不稳定型心绞痛接受了择期经皮冠状动脉血运重建术。
92.7%的患者尝试进行桡动脉插管,其中91.0%成功。88.7%的病变直接支架置入成功,手术成功率为99.3%。1.6%的患者发生院内主要不良心脏事件(1例死亡,1例半急诊冠状动脉搭桥手术)。通过5F引导导管成功植入支架的最终成功率为96.7%。无与穿刺部位相关的并发症。10%的尝试未能成功通过病变部位。出院后平均随访7±2.8个月,79%的患者无心绞痛发作,89%的患者无缺血事件。
采用新型支架设计的直接支架置入术安全、有效,可通过5F引导导管完成,且具有良好的长期临床结果。